Kathleen Palmer

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees et al. · JACC: Cardiovascular Interventions · 2017 · 310 citations

Medicine, Cardiology, Pharmacology +16

Safety and Immunogenicity of a Recombinant Multivalent Group A Streptococcal Vaccine in Healthy Adults

Karen L. Kotloff, Mary C. Corretti, Kathleen Palmer et al. · JAMA · 2004 · 173 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems

Jasmine A. Luzum, R E Pakyz, AR Elsey et al. · Clinical Pharmacology & Therapeutics · 2017 · 133 citations · Full text

Medicine, Pharmacology, Pharmacogenetics +14

Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics program

Alan R. Shuldiner, Kathleen Palmer, Ruth E. Pakyz et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2014 · 97 citations · Full text

Medicine, Genetics, Pharmacology +14

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

Robert Edelman, Kathleen Palmer, Karin Russ et al. · Vaccine · 1999 · 68 citations

Veterinary Medicine, Immunology, Infectious Diseases +12